Free Trial

NICE (NICE) Financials

NICE logo
$154.94 +2.32 (+1.52%)
Closing price 04:00 PM Eastern
Extended Trading
$154.82 -0.13 (-0.08%)
As of 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for NICE

Annual Income Statements for NICE

This table shows NICE's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
103 259 117 143 159 186 196 199 266 338 443
Consolidated Net Income / (Loss)
103 259 117 143 159 186 196 199 266 338 443
Net Income / (Loss) Continuing Operations
100 141 123 143 159 186 196 199 266 338 443
Total Pre-Tax Income
110 171 144 130 187 234 237 241 345 458 605
Total Operating Income
106 166 134 150 198 239 242 264 335 435 546
Total Gross Profit
568 623 678 863 948 1,042 1,086 1,297 1,498 1,609 1,826
Total Revenue
872 927 1,016 1,332 1,445 1,574 1,648 1,921 2,181 2,378 2,735
Operating Revenue
872 927 1,016 1,332 1,445 1,574 1,648 1,921 2,181 2,378 2,735
Total Cost of Revenue
304 304 338 469 497 532 562 624 684 768 910
Operating Cost of Revenue
304 304 338 469 497 532 562 624 684 768 910
Total Operating Expenses
462 457 544 713 750 803 844 1,033 1,162 1,174 1,280
Selling, General & Admin Expense
83 90 117 129 153 168 181 225 247 252 277
Marketing Expense
231 226 268 361 413 442 445 536 610 599 642
Research & Development Expense
123 128 142 181 184 194 218 271 306 323 361
Total Other Income / (Expense), net
3.77 5.30 10 -20 -11 -4.44 -4.86 -23 10 22 59
Other Income / (Expense), net
3.77 5.30 10 -20 -11 -4.44 -4.86 -23 10 22 59
Income Tax Expense
9.91 31 21 -14 27 48 41 41 79 119 162
Basic Earnings per Share
$1.74 $4.35 $1.96 $2.37 $2.60 $2.99 $3.13 $3.15 $4.17 $5.32 $6.97
Weighted Average Basic Shares Outstanding
59.36M 59.55M 59.67M 60.44M 61.39M 62.12M 62.71M 63.19M 63.79M 63.59M 63.48M
Diluted Earnings per Share
$1.69 $4.22 $1.92 $2.31 $2.52 $2.88 $2.98 $2.98 $4.00 $5.11 $6.76
Weighted Average Diluted Shares Outstanding
60.90M 61.28M 61.04M 62.12M 63.31M 64.66M 65.96M 66.90M 66.47M 66.27M 65.51M
Weighted Average Basic & Diluted Shares Outstanding
59.25M 59.53M 59.99M 60.93M 61.77M 62.40M 63.05M 63.48M 63.63M 62.87M 63.25M

Quarterly Income Statements for NICE

No quarterly income statements for NICE are available.


Annual Cash Flow Statements for NICE

This table details how cash moves in and out of NICE's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
68 138 -169 171 -86 -14 214 -64 154 -20 -28
Net Cash From Operating Activities
182 252 228 395 397 374 480 462 480 561 833
Net Cash From Continuing Operating Activities
182 252 228 395 397 374 480 462 480 561 833
Net Income / (Loss) Continuing Operations
103 259 117 143 159 186 196 199 266 338 443
Consolidated Net Income / (Loss)
103 259 117 143 159 186 196 199 266 338 443
Depreciation Expense
73 58 78 156 157 173 182 184 177 167 205
Amortization Expense
2.07 2.80 2.82 14 8.07 9.18 13 26 13 7.10 -8.03
Non-Cash Adjustments To Reconcile Net Income
25 -118 46 56 68 98 121 183 205 202 198
Changes in Operating Assets and Liabilities, net
-21 51 -16 25 3.81 -92 -32 -131 -181 -154 -5.01
Net Cash From Investing Activities
-8.93 -28 -800 -213 -461 -344 -465 -261 -152 -294 -397
Net Cash From Continuing Investing Activities
-8.93 -28 -800 -213 -461 -344 -465 -261 -152 -294 -397
Purchase of Property, Plant & Equipment
-18 -18 -36 -68 -64 -62 -63 -67 -82 -84 -100
Acquisitions
0.00 0.00 -1,156 -76 -105 -26 -147 -143 -30 -415 -65
Purchase of Investments
-144 -289 -49 -133 -430 -619 -583 -322 -396 -230 -938
Sale and/or Maturity of Investments
153 93 450 64 137 363 329 271 356 436 705
Net Cash From Financing Activities
-102 -79 405 -15 -16 -43 197 -262 -164 -290 -457
Net Cash From Continuing Financing Activities
-102 -79 405 -15 -16 -43 197 -262 -164 -290 -457
Repayment of Debt
0.00 0.00 -1.09 -260 -0.88 0.00 -215 -177 -20 -2.63 -192
Repurchase of Common Equity
-94 -68 -44 -24 -26 -47 -48 -73 -145 -288 -369
Payment of Dividends
-38 -38 -38 -9.64 - 0.00 0.00 -16 -0.38 -1.77 -3.04
Issuance of Common Equity
30 28 24 19 19 5.43 8.87 4.43 0.95 2.57 3.06
Other Financing Activities, net
1.05 -0.30 0.00 0.00 -8.44 -0.82 -0.18 - 0.00 0.00 105
Effect of Exchange Rate Changes
-3.56 -6.11 -2.55 4.42 -5.78 -0.98 1.87 -2.11 -8.43 2.64 -6.91
Cash Interest Paid
0.12 0.11 2.20 7.91 12 11 7.83 0.69 2.97 1.22 0.24
Cash Income Taxes Paid
33 54 28 33 43 65 83 97 124 210 120

Quarterly Cash Flow Statements for NICE

No quarterly cash flow statements for NICE are available.


Annual Balance Sheets for NICE

This table presents NICE's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
1,633 1,850 2,632 2,845 3,207 3,610 4,233 4,710 4,854 5,118 5,296
Total Current Assets
485 655 509 693 861 876 1,942 2,298 2,417 2,313 2,505
Cash & Equivalents
187 326 157 328 242 228 442 379 530 512 482
Short-Term Investments
66 99 30 64 244 211 1,022 1,046 1,042 896 1,140
Accounts Receivable
156 177 260 231 288 320 303 396 519 585 644
Prepaid Expenses
40 44 62 70 87 117 175 185 205 198 239
Other Current Assets
- - - - - - - 293 122 122 0.00
Plant, Property, & Equipment, net
40 41 88 118 140 142 138 146 159 174 185
Total Noncurrent Assets
1,107 1,154 2,035 2,034 2,206 2,593 2,153 2,267 2,278 2,630 2,606
Goodwill
660 651 1,285 1,318 1,366 1,378 1,503 1,607 1,617 1,822 1,850
Intangible Assets
110 68 619 551 508 411 366 295 210 306 231
Noncurrent Deferred & Refundable Income Taxes
19 14 14 12 12 31 33 55 117 179 219
Other Noncurrent Operating Assets
19 17 19 19 74 230 251 310 334 324 306
Total Liabilities & Shareholders' Equity
1,633 1,850 2,632 2,845 3,207 3,610 4,233 4,710 4,854 5,118 5,296
Total Liabilities
419 434 1,121 1,096 1,191 1,353 1,644 1,872 1,799 1,763 1,693
Total Current Liabilities
378 379 473 523 625 941 1,044 1,270 1,141 1,120 1,474
Short-Term Debt
- 0.00 21 0.00 0.00 252 260 396 209 209 459
Accounts Payable
202 235 302 339 404 422 450 524 579 595 704
Current Deferred Revenue
123 131 150 185 221 246 312 330 339 303 299
Other Current Liabilities
- - - - 0.00 22 22 20 14 14 13
Total Noncurrent Liabilities
41 56 648 572 566 412 600 603 658 643 218
Long-Term Debt
- 0.00 444 448 456 213 421 429 455 457 0.00
Noncurrent Deferred Revenue
- 20 23 38 35 26 36 67 57 52 66
Noncurrent Deferred & Payable Income Tax Liabilities
14 15 147 58 44 53 32 7.43 7.34 8.60 1.97
Other Noncurrent Operating Liabilities
19 18 34 29 31 120 110 100 138 125 150
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,213 1,415 1,511 1,750 2,017 2,257 2,588 2,838 3,055 3,355 3,603
Total Preferred & Common Equity
1,213 1,415 1,511 1,750 2,017 2,257 2,564 2,825 3,042 3,341 3,590
Total Common Equity
1,213 1,415 1,511 1,750 2,017 2,257 2,564 2,825 3,042 3,341 3,590
Common Stock
1,189 1,252 1,336 1,439 1,519 1,587 1,701 1,837 1,970 2,142 2,298
Retained Earnings
412 632 711 851 1,072 1,258 1,454 1,654 1,926 2,263 2,702
Treasury Stock
-377 -445 -489 -508 -527 -554 -574 -626 -743 -1,005 -1,339
Accumulated Other Comprehensive Income / (Loss)
-11 -24 -47 -33 -47 -33 -17 -40 -111 -59 -71
Noncontrolling Interest
- - - - - 0.00 25 13 13 13 13

Quarterly Balance Sheets for NICE

No quarterly balance sheets for NICE are available.


Annual Metrics and Ratios for NICE

This table displays calculated financial ratios and metrics derived from NICE's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
6.14% 6.29% 9.57% 31.18% 8.44% 8.96% 4.71% 16.57% 13.54% 9.00% 15.05%
EBITDA Growth
6.00% 25.17% -3.05% 33.34% 17.25% 18.40% 3.65% 4.44% 18.56% 18.21% 26.84%
EBIT Growth
38.64% 55.74% -15.71% -10.26% 44.00% 25.47% 1.24% 1.45% 43.52% 32.54% 32.14%
NOPAT Growth
93.93% 40.84% -16.10% 45.11% 1.68% 12.33% 5.77% 9.05% 18.13% 24.63% 24.19%
Net Income Growth
86.48% 151.11% -54.83% 22.55% 11.20% 16.67% 5.62% 1.47% 33.49% 27.21% 30.83%
EPS Growth
89.89% 149.70% -54.50% 20.31% 9.09% 14.29% 3.47% 0.00% 34.23% 27.75% 32.29%
Operating Cash Flow Growth
46.67% 38.44% -9.56% 72.94% 0.49% -5.66% 28.37% -3.85% 3.88% 17.03% 48.31%
Free Cash Flow Firm Growth
397.23% 33.45% -528.14% 118.73% -46.25% 92.45% -29.03% -258.32% 262.54% -141.01% 500.94%
Invested Capital Growth
-9.90% -13.62% 185.17% -1.09% 4.16% -0.06% 3.74% 23.96% -4.01% 21.62% -6.61%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
65.19% 67.25% 66.74% 64.82% 65.61% 66.21% 65.90% 67.50% 68.66% 67.69% 66.75%
EBITDA Margin
21.27% 25.05% 22.17% 22.53% 24.36% 26.47% 26.21% 23.48% 24.52% 26.59% 29.31%
Operating Margin
12.19% 17.92% 13.21% 11.27% 13.68% 15.17% 14.69% 13.74% 15.37% 18.31% 19.96%
EBIT Margin
12.62% 18.49% 14.23% 9.73% 12.93% 14.88% 14.39% 12.52% 15.83% 19.25% 22.11%
Profit (Net Income) Margin
11.82% 27.93% 11.51% 10.76% 11.03% 11.81% 11.91% 10.37% 12.19% 14.23% 16.18%
Tax Burden Percent
93.65% 151.00% 80.92% 110.51% 85.34% 79.35% 82.78% 82.80% 77.01% 73.91% 73.18%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
9.00% 17.99% 14.82% -10.51% 14.66% 20.65% 17.22% 17.20% 22.99% 26.09% 26.82%
Return on Invested Capital (ROIC)
13.36% 21.30% 10.01% 9.86% 9.88% 10.88% 11.30% 10.81% 11.77% 13.51% 15.81%
ROIC Less NNEP Spread (ROIC-NNEP)
12.05% 3.13% 9.19% -34.49% 15.16% 11.77% 11.92% 13.60% 10.73% 11.50% 11.29%
Return on Net Nonoperating Assets (RNNOA)
-4.84% -1.61% -2.02% -1.08% -1.42% -2.18% -3.20% -3.46% -2.74% -2.96% -3.09%
Return on Equity (ROE)
8.52% 19.69% 7.99% 8.79% 8.46% 8.70% 8.10% 7.34% 9.03% 10.56% 12.72%
Cash Return on Invested Capital (CROIC)
23.78% 35.92% -86.14% 10.96% 5.80% 10.94% 7.63% -10.59% 15.86% -5.99% 22.65%
Operating Return on Assets (OROA)
6.69% 9.84% 6.45% 4.73% 6.17% 6.87% 6.05% 5.38% 7.22% 9.18% 11.62%
Return on Assets (ROA)
6.27% 14.86% 5.22% 5.23% 5.27% 5.45% 5.01% 4.46% 5.56% 6.79% 8.50%
Return on Common Equity (ROCE)
8.52% 19.69% 7.99% 8.79% 8.46% 8.70% 8.06% 7.29% 8.99% 10.51% 12.67%
Return on Equity Simple (ROE_SIMPLE)
8.49% 18.29% 7.74% 8.19% 7.90% 8.24% 7.66% 7.05% 8.74% 10.13% 12.33%
Net Operating Profit after Tax (NOPAT)
97 136 114 166 169 189 200 219 258 322 400
NOPAT Margin
11.09% 14.70% 11.25% 12.45% 11.67% 12.04% 12.16% 11.37% 11.83% 13.53% 14.61%
Net Nonoperating Expense Percent (NNEP)
1.31% 18.17% 0.82% 44.36% -5.28% -0.89% -0.62% -2.79% 1.04% 2.02% 4.52%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 6.94% 8.00% 9.84%
Cost of Revenue to Revenue
34.81% 32.75% 33.26% 35.18% 34.39% 33.79% 34.10% 32.50% 31.34% 32.31% 33.25%
SG&A Expenses to Revenue
9.56% 9.75% 11.48% 9.69% 10.61% 10.68% 10.97% 11.73% 11.30% 10.61% 10.12%
R&D to Revenue
14.12% 13.86% 13.94% 13.60% 12.73% 12.31% 13.24% 14.12% 14.03% 13.57% 13.18%
Operating Expenses to Revenue
53.00% 49.33% 53.53% 53.55% 51.93% 51.05% 51.21% 53.76% 53.29% 49.38% 46.79%
Earnings before Interest and Taxes (EBIT)
110 171 144 130 187 234 237 241 345 458 605
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
185 232 225 300 352 417 432 451 535 632 802
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.45 2.37 2.70 3.15 3.27 4.25 6.90 6.78 4.01 3.80 2.97
Price to Tangible Book Value (P/TBV)
6.70 4.82 0.00 0.00 46.37 20.49 25.47 20.74 10.04 10.46 7.08
Price to Revenue (P/Rev)
3.41 3.62 4.02 4.14 4.56 6.09 10.74 9.96 5.60 5.34 3.90
Price to Earnings (P/E)
28.87 12.96 34.93 38.48 41.38 51.55 90.11 96.08 45.90 37.53 24.13
Dividend Yield
1.29% 1.13% 0.93% 0.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
3.46% 7.71% 2.86% 2.60% 2.42% 1.94% 1.11% 1.04% 2.18% 2.66% 4.14%
Enterprise Value to Invested Capital (EV/IC)
3.61 4.26 2.52 3.25 3.63 5.21 9.38 8.29 5.27 4.58 3.90
Enterprise Value to Revenue (EV/Rev)
2.84 2.73 4.20 4.08 4.37 5.76 10.28 9.66 5.19 5.03 3.48
Enterprise Value to EBITDA (EV/EBITDA)
13.35 10.88 18.94 18.11 17.95 21.76 39.21 41.14 21.15 18.93 11.88
Enterprise Value to EBIT (EV/EBIT)
22.50 14.74 29.50 41.92 33.84 38.70 71.40 77.12 32.76 26.15 15.75
Enterprise Value to NOPAT (EV/NOPAT)
25.60 18.55 37.30 32.78 37.46 47.86 84.52 84.92 43.83 37.20 23.85
Enterprise Value to Operating Cash Flow (EV/OCF)
13.59 10.01 18.68 13.77 15.93 24.23 35.26 40.18 23.58 21.32 11.44
Enterprise Value to Free Cash Flow (EV/FCFF)
14.39 11.00 0.00 29.51 63.82 47.59 125.23 0.00 32.51 0.00 16.65
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.31 0.26 0.23 0.21 0.26 0.29 0.22 0.20 0.13
Long-Term Debt to Equity
0.00 0.00 0.29 0.26 0.23 0.09 0.16 0.15 0.15 0.14 0.00
Financial Leverage
-0.40 -0.51 -0.22 0.03 -0.09 -0.19 -0.27 -0.25 -0.26 -0.26 -0.27
Leverage Ratio
1.36 1.32 1.53 1.68 1.61 1.60 1.62 1.65 1.62 1.56 1.50
Compound Leverage Factor
1.36 1.32 1.53 1.68 1.61 1.60 1.62 1.65 1.62 1.56 1.50
Debt to Total Capital
0.00% 0.00% 23.54% 20.37% 18.44% 17.08% 20.83% 22.53% 17.87% 16.57% 11.29%
Short-Term Debt to Total Capital
0.00% 0.00% 1.07% 0.00% 0.00% 9.24% 7.95% 10.81% 5.63% 5.20% 11.29%
Long-Term Debt to Total Capital
0.00% 0.00% 22.46% 20.37% 18.44% 7.84% 12.89% 11.72% 12.24% 11.37% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.75% 0.35% 0.36% 0.33% 0.33%
Common Equity to Total Capital
100.00% 100.00% 76.46% 79.63% 81.56% 82.92% 78.41% 77.12% 81.77% 83.10% 88.37%
Debt to EBITDA
0.00 0.00 2.07 1.49 1.30 1.12 1.58 1.83 1.24 1.05 0.57
Net Debt to EBITDA
0.00 0.00 0.80 -0.26 -0.78 -1.24 -1.81 -1.33 -1.70 -1.17 -1.45
Long-Term Debt to EBITDA
0.00 0.00 1.97 1.49 1.30 0.51 0.98 0.95 0.85 0.72 0.00
Debt to NOPAT
0.00 0.00 4.07 2.70 2.70 2.45 3.40 3.78 2.58 2.07 1.15
Net Debt to NOPAT
0.00 0.00 1.57 -0.47 -1.63 -2.73 -3.91 -2.74 -3.51 -2.31 -2.91
Long-Term Debt to NOPAT
0.00 0.00 3.89 2.70 2.70 1.13 2.10 1.96 1.76 1.42 0.00
Altman Z-Score
5.44 6.10 3.15 4.13 4.52 5.37 7.77 7.46 5.63 5.98 5.63
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.51% 0.69% 0.44% 0.42% 0.39%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.28 1.73 1.08 1.32 1.38 0.93 1.86 1.81 2.12 2.06 1.70
Quick Ratio
1.08 1.59 0.95 1.19 1.24 0.81 1.69 1.43 1.83 1.78 1.54
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
172 230 -983 184 99 191 135 -214 348 -143 572
Operating Cash Flow to CapEx
1,033.86% 1,403.69% 637.82% 581.88% 622.94% 603.75% 758.97% 687.11% 585.80% 666.95% 834.59%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.53 0.53 0.45 0.49 0.48 0.46 0.42 0.43 0.46 0.48 0.53
Accounts Receivable Turnover
5.06 5.57 4.64 5.43 5.57 5.18 5.29 5.50 4.77 4.31 4.45
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
20.64 22.95 15.83 12.94 11.17 11.16 11.80 13.56 14.31 14.25 15.21
Accounts Payable Turnover
1.38 1.39 1.26 1.46 1.34 1.29 1.29 1.28 1.24 1.31 1.40
Days Sales Outstanding (DSO)
72.19 65.56 78.63 67.26 65.53 70.45 68.96 66.37 76.48 84.72 82.01
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
265.27 262.39 290.08 249.46 272.68 283.34 283.31 284.65 294.47 278.95 260.53
Cash Conversion Cycle (CCC)
-193.07 -196.83 -211.45 -182.20 -207.15 -212.89 -214.35 -218.28 -217.99 -194.24 -178.52
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
686 593 1,690 1,672 1,742 1,741 1,806 2,238 2,149 2,613 2,440
Invested Capital Turnover
1.20 1.45 0.89 0.79 0.85 0.90 0.93 0.95 0.99 1.00 1.08
Increase / (Decrease) in Invested Capital
-75 -93 1,098 -18 70 -1.09 65 433 -90 464 -173
Enterprise Value (EV)
2,476 2,527 4,263 5,436 6,318 9,067 16,934 18,555 11,313 11,968 9,528
Market Capitalization
2,976 3,355 4,084 5,513 6,593 9,584 17,692 19,142 12,207 12,696 10,678
Book Value per Share
$20.19 $23.88 $25.39 $29.17 $33.10 $36.54 $41.09 $44.81 $47.92 $52.50 $57.10
Tangible Book Value per Share
$7.39 $11.74 ($6.59) ($2.00) $2.33 $7.57 $11.13 $14.64 $19.15 $19.07 $24.00
Total Capital
1,213 1,415 1,977 2,197 2,473 2,722 3,270 3,663 3,720 4,021 4,062
Total Debt
0.00 0.00 465 448 456 465 681 825 665 666 459
Total Long-Term Debt
0.00 0.00 444 448 456 213 421 429 455 457 0.00
Net Debt
-500 -828 179 -77 -275 -517 -783 -600 -907 -742 -1,163
Capital Expenditures (CapEx)
18 18 36 68 64 62 63 67 82 84 100
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-146 -149 -130 -223 -249 -253 -306 -0.51 -86 -6.05 -133
Debt-free Net Working Capital (DFNWC)
107 276 58 170 236 186 1,158 1,424 1,485 1,402 1,489
Net Working Capital (NWC)
107 276 36 170 236 -65 898 1,028 1,276 1,193 1,030
Net Nonoperating Expense (NNE)
-6.35 -123 -2.63 23 9.30 3.53 4.02 19 -7.82 -17 -43
Net Nonoperating Obligations (NNO)
-527 -822 179 -77 -275 -517 -783 -600 -907 -742 -1,163
Total Depreciation and Amortization (D&A)
75 61 81 170 165 182 195 210 189 174 197
Debt-free, Cash-free Net Working Capital to Revenue
-16.76% -16.06% -12.77% -16.71% -17.27% -16.06% -18.58% -0.03% -3.96% -0.25% -4.85%
Debt-free Net Working Capital to Revenue
12.28% 29.81% 5.67% 12.74% 16.36% 11.84% 70.25% 74.13% 68.09% 58.96% 54.44%
Net Working Capital to Revenue
12.28% 29.81% 3.59% 12.74% 16.36% -4.15% 54.48% 53.52% 58.49% 50.16% 37.67%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.74 $4.35 $1.96 $2.37 $2.60 $2.99 $3.13 $3.15 $4.17 $5.32 $6.97
Adjusted Weighted Average Basic Shares Outstanding
59.36M 59.55M 59.67M 60.44M 61.39M 62.12M 62.71M 63.19M 63.79M 63.59M 63.48M
Adjusted Diluted Earnings per Share
$1.69 $4.22 $1.92 $2.31 $2.52 $2.88 $2.98 $2.98 $4.00 $5.11 $6.76
Adjusted Weighted Average Diluted Shares Outstanding
60.89M 61.28M 61.04M 62.12M 63.31M 64.66M 65.96M 66.90M 66.47M 66.27M 65.51M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
59.25M 59.53M 59.99M 60.93M 61.77M 62.40M 63.05M 63.48M 63.63M 62.87M 63.25M
Normalized Net Operating Profit after Tax (NOPAT)
102 136 114 105 169 189 200 219 258 322 400
Normalized NOPAT Margin
11.66% 14.70% 11.25% 7.89% 11.67% 12.04% 12.16% 11.37% 11.83% 13.53% 14.61%
Pre Tax Income Margin
12.62% 18.49% 14.23% 9.73% 12.93% 14.88% 14.39% 12.52% 15.83% 19.25% 22.11%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
37.00% 14.77% 32.67% 6.73% 0.00% 0.00% 0.00% 7.91% 0.14% 0.52% 0.69%
Augmented Payout Ratio
128.46% 41.19% 69.99% 23.77% 16.32% 25.43% 24.59% 44.64% 54.64% 85.79% 84.10%

Quarterly Metrics and Ratios for NICE

No quarterly metrics and ratios for NICE are available.


Frequently Asked Questions About NICE's Financials

When does NICE's fiscal year end?

According to the most recent income statement we have on file, NICE's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has NICE's net income changed over the last 10 years?

NICE's net income appears to be on an upward trend, with a most recent value of $442.59 million in 2024, rising from $103.08 million in 2014. The previous period was $338.30 million in 2023.

What is NICE's operating income?
NICE's total operating income in 2024 was $545.95 million, based on the following breakdown:
  • Total Gross Profit: $1.83 billion
  • Total Operating Expenses: $1.28 billion
How has NICE revenue changed over the last 10 years?

Over the last 10 years, NICE's total revenue changed from $872.00 million in 2014 to $2.74 billion in 2024, a change of 213.7%.

How much debt does NICE have?

NICE's total liabilities were at $1.69 billion at the end of 2024, a 4.0% decrease from 2023, and a 303.5% increase since 2014.

How much cash does NICE have?

In the past 10 years, NICE's cash and equivalents has ranged from $157.03 million in 2016 to $529.60 million in 2022, and is currently $481.71 million as of their latest financial filing in 2024.

How has NICE's book value per share changed over the last 10 years?

Over the last 10 years, NICE's book value per share changed from 20.19 in 2014 to 57.10 in 2024, a change of 182.8%.

Remove Ads


This page (NASDAQ:NICE) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners